The Office of Research Bridge Funding opportunity opens October 1, 2026, for FY27 funding. See the website for the RFA and details. The application deadline is December 1, 2026.

IBC Approval for Human Work

Is this human or non-human?

Human clinical trials involving recombinant/synthetic nucleic acid molecules (r/sNA) must go through the Tulane IBC administered by WCG-IRB IBC Services. To get the correct protocol forms for human research involving r/sNA, please contact IBC Services at IBCServices@wcgirb.com and one of their IBC specialists will help you prepare your project’s submission for review.